Role of potential Biomarkers in the efficacy of glatiramer acetate in subjects with relapsing-remitting multiple sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 17 May 2016
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 17 May 2016 New trial record